An algorithm to identify medication nonpersistence using electronic pharmacy databases
暂无分享,去创建一个
Andrew J. Karter | Melissa M. Parker | Howard H. Moffet | Alyce Adams | A. Karter | H. Moffet | A. Adams | Melissa M. Parker
[1] K. Chan,et al. Methods for evaluation of medication adherence and persistence using automated databases , 2006, Pharmacoepidemiology and drug safety.
[2] Rishi Sikka,et al. Estimating medication persistency using administrative claims data. , 2005, The American journal of managed care.
[3] N. Krieger. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. , 1992, American journal of public health.
[4] P Michael Ho,et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. , 2008, American heart journal.
[5] C. Rand,et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. , 1999, Medical care.
[6] M. Sevick,et al. Medication nonadherence: a diagnosable and treatable medical condition. , 2013, JAMA.
[7] David L McClure,et al. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease , 2006, BMC cardiovascular disorders.
[8] Romain Neugebauer,et al. Cohort Profile: The Diabetes Study of Northern California (DISTANCE)--objectives and design of a survey follow-up study of social health disparities in a managed care population. , 2009, International journal of epidemiology.
[9] N. Keiding,et al. Validation of methods for identifying discontinuation of treatment from prescription data , 2010 .
[10] Jennifer Y. Liu,et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. , 2001, The American journal of medicine.
[11] J. Liberman,et al. Recent trends in the dispensing of 90-day-supply prescriptions at retail pharmacies: implications for improved convenience and access. , 2011, American health & drug benefits.
[12] Harlan M Krumholz,et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. , 2006, Archives of internal medicine.
[13] M. Abrahamowicz,et al. Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study , 2011, Annals of the rheumatic diseases.
[14] Anuja Roy,et al. Medication compliance and persistence: terminology and definitions. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[15] Yongfei Wang,et al. Discontinuation of Antihyperglycemic Therapy and Clinical Outcomes After Acute Myocardial Infarction in Older Patients With Diabetes , 2010, Circulation. Cardiovascular quality and outcomes.
[16] M Alan Brookhart,et al. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. , 2007, Archives of internal medicine.
[17] T D Koepsell,et al. A General Method of Compliance Assessment Using Centralized Pharmacy Records: Description and Validation , 1988, Medical care.
[18] J. Steiner,et al. Standardizing Terminology and Definitions of Medication Adherence and Persistence in Research Employing Electronic Databases , 2013, Medical care.
[19] Melissa M. Parker,et al. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. , 2009, Health services research.
[20] S. Morgan,et al. Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization. , 2006, Clinical therapeutics.
[21] R. Marshall,et al. Maintenance of statin use over 3 years following acute coronary syndromes: a national data linkage study (ANZACS-QI-2) , 2014, Heart.
[22] M. Taitel,et al. Medication days' supply, adherence, wastage, and cost among chronic patients in Medicaid. , 2012, Medicare & medicaid research review.
[23] Amy M. Bauer,et al. Associations Between Antidepressant Adherence and Shared Decision-Making, Patient–Provider Trust, and Communication Among Adults with Diabetes: Diabetes Study of Northern California (DISTANCE) , 2014, Journal of General Internal Medicine.
[24] A. de Boer,et al. Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation. , 2006, Journal of clinical epidemiology.
[25] H. S. Lau,et al. Validation of pharmacy records in drug exposure assessment. , 1997, Journal of clinical epidemiology.
[26] Niels Keiding,et al. Estimating the effect of current, previous and never use of drugs in studies based on prescription registries , 2009, Pharmacoepidemiology and drug safety.
[27] K. Olson,et al. Out-of-plan pharmacy use by members of a managed care organization. , 2012, The Permanente journal.
[28] D. Alter,et al. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. , 2007, JAMA.
[29] R. Hiatt,et al. Characteristics of patients referred for treatment of end-stage renal disease in a defined population. , 1982, American journal of public health.
[30] M. Hudson,et al. Comparison of measures of medication persistency using a prescription drug database. , 2007, American heart journal.
[31] Melissa M. Parker,et al. Glycemic response to newly initiated diabetes therapies. , 2007, The American journal of managed care.
[32] S. Johansson,et al. Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care , 2011, BMJ : British Medical Journal.
[33] S. Erickson,et al. The Concordance of Self-Report With Other Measures of Medication Adherence: A Summary of the Literature , 2004, Medical care.